| Literature DB >> 30225299 |
Vladimir F Lazarev1, Elizaveta A Dutysheva1, Elena Y Komarova1, Irina V Guzhova1, Boris A Margulis1.
Abstract
These data are related to our paper "GAPDH-targeted therapy - a new approach for secondary damage after traumatic brain injury on rats" (Lazarev et al., In press), in which we explore the role of exogenous GAPDH in traumatic brain injury-induced neuron death, and the therapeutic application of small molecules that bind to the enzyme. The current article demonstrates the induction of apoptosis by exogenous GAPDH and the effectiveness of the hydrocortisone derivative for suppressing the pathogenic action of the enzyme.Entities:
Year: 2018 PMID: 30225299 PMCID: PMC6138975 DOI: 10.1016/j.dib.2018.08.093
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1The data of ultrafiltration of different GAPDH fractions accompanied by a subsequent conjugation with anti-GAPDH 6C5 antibodies are shown.
Fig. 2Different GAPDH fractions were incubated with SH-SY5Y cells for 1, 3, 5, 12 or 24 h. The proportion of apoptotic cells was measured using acridine orange staining.
Fig. 3Different GAPDH fractions were incubated with SH-SY5Y for 24 h in the presence of various concentrations of RX624 (from 0.1 to 10 μM). The proportion of apoptotic cells was measured as in Fig. 1.
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |